Literature DB >> 12114100

Lipomatus hypertrophy of the atrial septum and prominent crista terminalis appearing as a right atrial mass.

J R Pharr1, V M Figueredo.   

Abstract

In these case reports, transthoracic echocardiography suggested the presence of a right atrial mass. However, subsequent transoesophageal echocardiography revealed that the 'right atrial mass' was actually a lipomatous hypertrophied atrial septum in combination with a prominent crista terminalis. An understanding of the anatomy and the echocardiographic appearance of a lipomatous hypertrophied atrial septum appearing with a prominent crista terminalis will minimize the misdiagnosis of these structures. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12114100     DOI: 10.1053/euje.2001.0132

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  4 in total

1.  Prominent crista terminalis in patients with embolic events.

Authors:  Jin Oh Na; Eung Ju Kim; Sun Joung Mun; Eun Hee Choi; Jin Hee Mun; Hye Ra Lee; Yun Kyung Kim; Hwan Seok Yong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30

2.  Prominent crista terminalis mimicking a right atrial mass: case report.

Authors:  Alessandro Salustri; Sherif Bakir; Amer Sana; Peter Lange; Wael Abdulrahman Al Mahmeed
Journal:  Cardiovasc Ultrasound       Date:  2010-10-19       Impact factor: 2.062

3.  Irregular connexin43 expressed in a rare cardiac hamartoma containing adipose tissue in the crista terminalis.

Authors:  Pao-Hsien Chu; Hung-I Yeh; Shih-Ming Jung; Li-Ying Chien; Nai-Feng Cheng; Hsueh-Hua Wu; Jaw-Ji Chu; Chuen Hsueh; Ying-Shiung Lee
Journal:  Virchows Arch       Date:  2004-01-27       Impact factor: 4.064

4.  Lipomatous hypertrophy of the interatrial septum: a commonly misdiagnosed mass often leading to unnecessary cardiac surgery.

Authors:  I Nadra; D Dawson; S A Schmitz; P P Punjabi; P Nihoyannopoulos
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.